Novozymes A/S (NVZMY) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Novozymes A/S

    OTC: NVZMY · Real-Time Price · USD
    60.28
    -0.02 (-0.03%)
    At close: Sep 24, 2025, 3:59 PM
    60.34
    0.11%
    After-hours: Sep 24, 2025, 03:50 PM EDT

    Novozymes A/S Income Statement

    Financials in EUR. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 3.83B 17.9B 17.55B 14.95B
    Cost of Revenue
    		 2.02B 8.18B 7.96B 6.33B
    Gross Profit
    		 1.81B 9.72B 9.58B 8.62B
    Operating Income
    		 659M 3.98B 4.63B 4.01B
    Interest Income
    		 26.9M 16.74M 18M 18M
    Pretax Income
    		 417.1M 3.91B 4.56B 3.92B
    Net Income
    		 305.8M 3.02B 3.68B 3.15B
    Selling & General & Admin
    		 765.5M 3.32B 3.22B 2.79B
    Research & Development
    		 413.2M 2.02B 2B 2.01B
    Other Expenses
    		 -28.2M 405M -37.04M -66M
    Operating Expenses
    		 1.15B 5.75B 5.03B 4.74B
    Interest Expense
    		 76.4M 23.24M 102M 102M
    Selling & Marketing Expenses
    		 550.9M 2.37B 2.27B 1.94B
    Cost & Expenses
    		 3.17B 13.92B 13.13B 11.07B
    Income Tax Expense
    		 111.3M 870M 870M 779M
    Shares Outstanding (Basic)
    		 456.42M 277.94M 278.7M 277.92M
    Shares Outstanding (Diluted)
    		 456.42M 277.87M 278.73M 280.23M
    EPS (Basic)
    		 0.67 10.88 13.29 11.32
    EPS (Diluted)
    		 0.67 10.88 13.19 11.23
    EBITDA
    		 8.07B 5.47B 6.12B 5.2B
    EBIT
    		 6.29B 4.08B 4.66B 4.03B
    Depreciation & Amortization
    		 1.78B 1.39B 1.46B 1.37B

    Add to Watchlist